Active Pharmaceutical Ingredient (API)

Neostigmine Methylsulphate

Acetylcholinesterase Inhibitor (Reversal)

A reversible acetylcholinesterase ($\text{AChE}$) inhibitor used to reverse the effects of non-depolarizing neuromuscular blocking agents (like Rocuronium) after surgery. By blocking $\text{AChE}$, it increases acetylcholine at the neuromuscular junction, restoring muscle strength.
Technical Profile
Reference Code
NEO288
CAS Number
51-60-5
Chemical Class
N/A
Therapeutic Class
N/A

Verified Brands

Medicines containing Neostigmine Methylsulphate as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.